# Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

> **NCT02147691** · PHASE4 · COMPLETED · sponsor: **Derm Research, PLLC** · enrollment: 22 (actual)

## Conditions studied

- Acne Rosacea

## Interventions

- **DRUG:** Azelaic acid 15%
- **DRUG:** Brimonidine 0.33%

## Key facts

- **NCT ID:** NCT02147691
- **Lead sponsor:** Derm Research, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2015-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02147691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02147691, "Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02147691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*